Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. (Q42509333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Anna K Manlapat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

David J Kahler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Phillip R Chandler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Andrew L Mellor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1064-1071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

Tolerance, DCs and tryptophan: much ado about IDO

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Inhibition of experimental asthma by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

IDO and tolerance to tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Mechanisms of type-I- and type-II-interferon-mediated signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Coping with stress: eIF2 kinases and translational control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Tissue-specific positive feedback requirements for production of type I interferon following virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

IRF-7 is the master regulator of type-I interferon-dependent immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636690

7 January 2021

Identifiers

DOI

10.1002/EJI.200636690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17343295%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference